Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
What causes people to get cancer essay
Many causes of cancer
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: What causes people to get cancer essay
Cancer is an important health problem that has strongly increased over the past couple of decades. According to the American Cancer Society, approximately 1,638,910 people in the United States are diagnosed with cancer each year; that is around 187 people per minute. This disease is ranked as the second most common cause of death in America. With cancer being so common today, there needs to be an effective and relatively fast treatment plan to cure the victims of cancer without causing more harm to them. Extensive research and analysis is critical to determine the best method of treatment. Cancer can be fatal but recent advancement and better understanding of the disease has produced major triumph in overcoming the ailment. Aside from patients feeling overwhelmed by being diagnosed with cancer, it can be extremely difficult and stressful to make a decision like this that will ultimately lead to life or death. The best treatment plan for cancer patients today is most likely combining CAM and drug treatments to lower the amount of side effects while shrinking the tumor size and inhibiting any further growth, thus curing the patient.
There are a variety of forms of cancer which makes it harder on the doctor and patient to choose a treatment plan. The two most common types of cancer are breast and colon cancer. It is already estimated that over 300,000 people will be diagnosed specifically with these two types of cancer by the end of this year (ACS, 2012). This number needs to be lowered but before that can happen an effective and reliable treatment plan needs to be established. This plan will not only help current and future patients conquer cancer, it will provide valuable information about the disease and doctors and scientists can...
... middle of paper ...
... 207-214.
Patyar, S., Joshi, R., Prasad, D., Prakash, A., Medhi, B., and Das, B. (2010). Bacteria in cancer therapy: a novel experimental strategy. Journal of Biomedical Science, 17. doi:10.1186/1423-0127-17-21
Prica, A., Chan, K., & Cheung, M. (2012). Combined modality therapy versus chemotherapy as an induction regimen for primary central nervous system lymphoma: a decision analysis. British Journal Of Haematology, 158, 600-607.
Urruticoechea, A., Alemany, R., Balart, J., Villanueva, A., Vinals, F., Capella, G. (2010). Recent advances in cancer therapy: an overview. Current Pharmaceutical Design, 16, 3-10.
Veracity, D. (2005). Killer cancer treatment: How toxic chemotherapy kills both cancer cells and cancer patients. Natural News: Natural Health News and Scientific Discovery, 5. Retrieved from http://www.naturalnews.com/012727_chemotherapy_cancer_treatments.html
The main idea of this study is to underscore: "the need to validate potential cellular targets for adjuvant and systemic therapies on disseminated cancer cells directly"( Cancer Cell: July 2003).
Chemotherapy is the treatment of a tumor with chemical agents to reduce mass or eradicate a tumor completely. There are certain mechanisms by which chemotherapy inhibits cancer. The first mechanism is cell death by cytotoxicity. Some chemical agents in certain amounts are toxic to cells. The cells die due to the toxic...
I have elected to transcribe my proposal argument on issues regarding cancer chemoprevention. I selected this topic because reasonably minute devotion has been given to cancer chemoprevention research in ethical writings, particularly in relation to the huge quantity of moral studies in cancer treatment exploration. Cancer chemoprevention trials test the ability and care of medicinal agents in averting cancer before its manifestation. I believe that phase III chemoprevention issues can be less prevalent by simply ensuring enhanced communication and etiquette between researchers and investigators.
Chemotherapy drugs are more dangerous than other drugs because of their narrow therapeutic index. What is therapeutic index you ask? It is the ratio between a toxic dose and a therapeutic dose of a drug so any medication error with chemotherapy drugs could be a fatal one. Chemotherapy drugs can be very toxic even at the prescribed therapeutic level recommended by the physician. The findings in this article shows that the patient themselves are the first line of defense in spotting errors in medications they receive because they obs...
Breast Cancer is defined as “a group of solid tumor malignancies arising in the tissues of the breast” (Sarah Crawford, Richard Alder, 2013) in human and other mammals. It can happen to both men and women. For women, breast cancer is one of the leading causes of cancer death. According to National Cancer Institute, in the United States, the 2014 estimated new cases and deaths of female from breast cancer are 232,670 and 40,000, respectively. For male, it’s 430 deaths out of 2,360 new cases. From these numbers, we can see that women in the U.S. are greatly affected by breast cancer, thus, it’s not difficult to imagine the impact on a worldwide level. Although these numbers look frightening, people can actually survive from breast cancer if it is detected early and treated properly, so it is extremely important for all of us, especially women, to have a better understanding of breast cancer.
Cancer is one of the leading causes of death worldwide as it can develop in almost any organ or tissue. Significant advances in understanding the cellular basis of cancer and the underlying biological mechanisms of tumour has been vastly improved in the recent years (Jiang et al. 1994). Cancer is a genetic disease which requires series of mutation during cell division to develop, it has characteristics which can be associated with their ability to grow and divide abnormal cells uncontrollable while in the mean time invade and cause nearby blood vessels to serve its need. Even though many people are affected by cancer today, the abilities which cancer cells own make it hard to find single effective treatment for cancer. The focus of research now lies on developing drugs which target cancer cells in the hope to cure cancer once and for all.
Annually, over half a million people die of cancer, but behind the scenes of the Federal Drug Administration (FDA) are several promising treatments that will probably never see the light of day. In 1994, a new drug called Angiostatin was created. This new treatment presumably could halt malignant tumors and reverse the harmful effects of cancer. Set up by the FDA, a clinical trial equipped with the use of the medicine in animals began soon after the discovery. The results of the trial showed that in three different types of cancer, Angiostatin ranged from 90-98% effective in ridding the cancer. Even with the astounding conclusions from the clinical trial, the FDA waited another six years to approve Angiostatin. In those six years, more than three million people diagnosed with cancer died, and part of those three million could have been saved with the use of Angiostatin, but the FDA dragged on the process of approving it (Falloon 3). Terminally ill patients need medication, even if not FDA approved, given that the risks and benefits are accurately portrayed.
The American Cancer Society publishes current advances made in cancer research on their website. Many of the exciting discoveries about how best to treat the disease focus on the genetic aspects associated with certain types of cancer. In addition, treatments aimed at genetic solutions to cancer may be more effective and may cause fewer adverse side effects than traditional cancer treatments (American Can...
For years, people have been looking for a cure for the devastating disease of cancer. Cancer is the third highest killer in the US, with over 2,500,000 victims per year. Oncologists and scientists around the country are researching all forms of cancer in an effort to understand, treat, and ultimately defeat this disease. Already there have been numerous advances in the field, such as chemotherapy and gene therapy. One advance has been the use of a cell process known as apoptosis.
Bioengineering analysis is pointing a new way to better drug designs and better drug testing. The disease of cancer has taken the life of many patients, but through new medicines and procedures many more are surviving. A significant progress has been made against cancer, allowing people to live longer and fuller lives. There have been more than one-million less cancer deaths since 1990and 1991(aacr.org). On January 1, 2012 there were 13.7 million survivors in the United States. These numbers are achieved by using new techniques to cure cancer like, immunotherapies to avoid toxins, Targeted cancer therapies to target different types of cancer, and weakling cancerous tumors making them susceptible to drugs. Cancer is still a significant problem and is far from being cured, but step by step biomedical engineers are getting closer and closer.
Cancer is the uncontrolled growth of abnormal cells in the body. Tumors are then created and interfering with the digestive, nervous and circulatory systems. It is one of the most leading causes of death, reaching at about 8.2 million deaths in 2012. It is expected that cancer will rise from 14 million to 22 million within the next 2 decades. With over 100 cancer research centers in the United States studying how to treat this disease, people need to understand the importance of donating also with the awareness of signs and symptoms in the early stages. But, what are we doing about it? Do we have the technology to finally be able to put this deadly disease to an end?
Bacteria are found nearly everywhere within the body and most types are harmless or even helpful to bodily function (Novitt-Moreno). While it is important to have these bacteria in the body, pathogenic invaders can cause serious illnesses. Pathogenic bacteria work by either actually attacking a part of the victim’s body or releasing toxic waste products into the body. Bacteria are single-celled and contain all of the cellular mechanisms needed to live, grow, and reproduce (Novitt-Moreno). That means, when treating a bacterial infection, it is critical to have a highly specific antibiotic that can destroy the unwanted
The major concern behind CAM is that it covers a rather broad range of therapies, most of which have not been able to establish any proper scientific basis. This results in a lot of objection from the researchers and collegiate officials that it does not qualify to obtain its place as important learning in the medical school curricula. However, cancer patients have said that they have benefited from CAM therapies, during and after their exhaustive treatments. This shows that there is scope for some CAM methods to be legitimate.
What exactly is Chemotherapy and why would it also kill “good” cells? Cancer could be described as the disease that sends cells out of control, rapidly multiplying the cells, until it harms the body. Chemotherapy is an effective drug treatment intended to treat individuals with various forms of cancer. Generally, this type of treatment is nonspecific, and non-molecular that uses chemical agents to break down all dividing cells. Chemotherapy, or chemo for short, destroys cancer cells, and can also cease the reproduction or spreading of these cells. Despite having apparent benefits, this type of treatment comes at a cost, presenting several disadvantages and side effects. Chemotherapy comes with a heavy burden, nausea and vomiting, diarrhea, anemia, infections, and fatigue is a few of the short-term side effects. This analysis examines chemotherapy as a type of cancer treatment, as well as evaluating complimentary and alternative medicines.
Hodgkin's and Non-Hodgkin's Lymphoma: Differences? and similarity on MedicineNet.com. Retrieved December 9, 2013, from http://www.cdl.gov http://www.medicinenet.com/script/main/art.asp?articlekey=79261 Turley, Susan M. (2014). The 'Path of Medical language (third ed.). Upper Saddle River, NJ: Pearson. Education & Training, Inc. Zimmerman, K. A. & Co.,